Chapter Member Anniversaries: July 2019

Posted by ISPE Boston
On August 5, 2019

Please congratulate the following members celebrating milestone anniversaries in July 2019. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Michael A. Arnold, RPh, Pfizer Global Clinical Supplies Oliver W. Bausch, Bausch Advanced Tech. Dr. James V. Blackwell, PhD, MBA, The Windshire Group, LLC Richard V. Bodmer, […]

Welcome New Members!

Posted by ISPE Boston
On August 5, 2019

We would like to introduce the Members who joined ISPE in July 2019, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

Looking Back, Again – Reflecting on My Term as Boston Area Chapter President & Welcoming the New Board

Posted by Kevin Chronley
On July 31, 2019

Serving this past year as the Boston Area Chapter President was both a great pleasure and a humbling experience. I had the unique opportunity of formerly serving as President of the New England Chapter and initiating the process of merging the Chapters into the current Boston Area Chapter. Therefore, beyond the task of leading the […]

Pfizer’s Upjohn + Mylan = Off-Patent/Generics Powerhouse

Posted by ISPE Boston
On July 31, 2019

Mylan and Pfizer have announced a definitive agreement to combine Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business, creating a new global pharmaceutical company. Under the terms of the agreement, each Mylan share would be converted into one share of the new company. Pfizer shareholders would own 57% of the combined new […]

Make your Voice Heard – ISPE International Elections are Open!

Posted by ISPE Boston
On July 31, 2019

Have you voted in the 2019 ISPE International Board election yet? As an ISPE Member, you can help shape the future of the Society by voting for representatives to fill open seats on the International Board of Directors. The Board establishes the Society’s vision and mission, articulates strategic priorities, and ensures that business operations are consistent […]

Lyndra Therapeutics to Collaborate with Gilead on HIV Therapies

Posted by ISPE Boston
On July 25, 2019

Watertown-based Lyndra Therapeutics recently announced a partnership with Gilead Sciences to develop and commercialize ultra-long-acting oral HIV therapies. This partnership announcement comes just months after Gilead joined Lyndra’s $60.9 million Series B financing round. Gilead will have exclusive rights to Lyndra’s therapeutics platform for ultra-long-acting formulations related to HIV. Lyndra’s ultra-long-acting dosage form has the […]

Kronos Bio Completes $105 Million Financing Round

Posted by ISPE Boston
On July 25, 2019

“We are excited to have the continued support of high caliber investors who recognize the potential of Kronos’ technology and its team. This financing will help us advance two preclinical programs…, accelerate our research, and further expand the Kronos team in the Boston and San Francisco areas,” said Norbert Bischofberger, Ph.D., President and Chief Executive […]

Red Sox Loss Can’t Spoil the Fun

Posted by Kayla Hannon
On July 18, 2019

The Boston Area Chapter Young Professionals held their annual – and ever-popular – Red Sox summer outing on Tuesday, July 16. The event was another huge success with over 40 biotech and pharma professionals of all ages coming out for the game. Everyone met at the Bullpen Kitchen + Tap prior to the game to […]

Planning a Successful Warehouse Thermal Mapping Study

Posted by Alex Debreceni
On July 18, 2019

Pharmaceutical, biological and medical device products require controlled environmental storage conditions. Degradation can occur when the storage environment of the product exceeds the range of safe conditions of the product. For example, some pharmaceutical materials need to be stored at ambient temperature to preserve the potency of the product. If the temperature of the storage […]

Frequency Therapeutics Inks $80M Deal with Astellas

Posted by ISPE Boston
On July 18, 2019

Woburn-based Frequency Therapeutics has entered into an exclusive license agreement with Tokyo’s Astellas Pharma to develop and commercialize Frequency’s regenerative therapeutic candidate, FX-322, for the treatment of sensorineural hearing loss, the most common type of hearing loss. At present, there are no approved therapeutic options for sensorineural hearing loss. Frequency will receive an upfront payment […]

Page 80 of 118«‹78 798081 82 ›»